Universal Health (UHS) Tops Q2 EPS by 42c, Offers Guidance
Tweet
Share
E-mail
Get Alerts UHS Hot Sheet
Price: $170.33 +0.12%
Revenue Growth %: +4.9%
Financial Fact:
Depreciation and amortization: 103.71M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Revenue Growth %: +4.9%
Financial Fact:
Depreciation and amortization: 103.71M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Universal Health (NYSE: UHS) reported Q2 EPS of $5.35, $0.42 better than the analyst estimate of $4.93. Revenue for the quarter came in at $4.28 billion versus the consensus estimate of $4.24 billion.
GUIDANCE:
Universal Health sees FY2025 EPS of $20.00-$21.00, versus the consensus of $19.58. Universal Health sees FY2025 revenue of $17.1-17.31 billion, versus the consensus of $17.13 billion.
For earnings history and earnings-related data on Universal Health (UHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic jumps on earnings beat and raised guidance
- Chardan Assumes Rocket Pharmaceuticals (RCKT) at Buy
- Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
